Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rang în acțiuni #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Preț acțiune
$0.21483059
Ultima sincronizare: 2024-05-07
Capitalizare de piață
$11.13M
Schimbare (1 zi)
0.34%
Schimbare (1 an)
0.00%
Țară
CA
Tranzacționează Antibe Therapeutics Inc. (ATE)

Categorie

Prețul ATE cu capitalizarea de piață a B
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
ATE
$0.21483059
Capitalizarea de piață a Antibe Therapeutics Inc.(ATE)
Capitalizare de piață: $11.13M
În anul August 2026, Antibe Therapeutics Inc. are o capitalizare de piață de $11.13M. Acest lucru face ca Antibe Therapeutics Inc. să fie a 32097th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Antibe Therapeutics Inc. din 2013 până în 2026
ATE în comparație cu top 5 cele mai populare stocks
Prețul pentru ATE Activul B Capitalizarea de piață a B Rezultate
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$105,363 $11.13M
$5.460T +49,044,735.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$86,632.75 $11.13M
$4.489T +40,325,975.22%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$79,906.01 $11.13M
$4.141T +37,194,795.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$68,861.34 $11.13M
$3.569T +32,053,685.74%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$53,993.05 $11.13M
$2.798T +25,132,751.91%